Cohort of Hospitalized Patients Suspected of Leptospirosis (COLEPT)

Institut National de la Santé Et de la Recherche Médicale, France

Status: Active, not recruiting

Conditions: Leptospirosis

Treatments: Other: Blood and urine sampling and blood banking

Study type: Interventional

Funder types: Other

Identifiers

NCT04034550

C17-47

Details and patient eligibility

About

COLEPT is a prospective interventional study that intends to better inform about leptospirosis, a neglected zoonotic infectious disease. During prospective follow-up of hospitalized acute leptospirosis cases, the participants will be assessed during 1 year for epidemiological, clinical, bacteriological and immunological data. Main intervention consists in blood sampling and biological bank constitution.

Enrollment: 200 estimated patients

Sex: All

Ages: 1+ day old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• clinico-biological manifestations compatible with acute leptospirosis OR proven leptospirosis with serological testing or PCR
• onset of symptoms within 21 days
• participant benefits of health insurance

Exclusion criteria

• participant's refusal, or refusal from his relatives in case of major incapacity of the eligible participant precluding expression of his will (coma, stay in intensive care unit))

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

200 participants in 1 patient group

hospitalized patients diagnosed with leptospirosis

Experimental group

Description:

hospitalized patients diagnosed with leptospirosis: 12 months of follow up with biological samples and data collection

Treatment:

Other: Blood and urine sampling and blood banking